英文字典中文字典51ZiDian.com

中文字典辞典英文字典 a b c d e f g h i j k l m n o p q r s t u v w x y z

mesoblast

n. 中胚叶

中胚叶

WordNet (r) 3.0 (2006) (WordNet)

mesoblast
n 1: the middle germ layer that develops into muscle and bone
and cartilage and blood and connective tissue [synonym:
{mesoderm}, {mesoblast}]

The Collaborative International Dictionary of English v.0.48 (gcide)

Mesoblast \Mes"o*blast\, n. [Meso- -blast.] (Biol.)
(a) The mesoderm.
(b) The cell nucleus; mesoplast.
[1913 Webster]

请选择你想看的字典辞典：

单词	字典	翻译
mesoblast	查看　mesoblast　在百度字典中的解释	百度英翻中〔查看〕
mesoblast	查看　mesoblast　在Google字典中的解释	Google英翻中〔查看〕
mesoblast	查看　mesoblast　在Yahoo字典中的解释	Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!

中文字典英文字典工具:

选择颜色:

<style type="text/css">#word104_1 br {display:none;}</style>
<form id="word104_1" method="post" action="http://no.goldgoldprice.com/index.php" target="_blank">
<div style="width: 140px;border:1px solid #000;background-color:#ffffff;padding: 0px 0px;margin: 0px 0px;align:center;text-align:center;overflow:hidden;"><div id="xcolor1_1" style="font-size:12px;color:#183a00;line-height:16px;font-family: arial; font-weight:bold;background:#94abf0;padding: 3px 1px;text-align:center;"><a href="http://no.goldgoldprice.com/" alt="英文字典中文字典" title="英文字典中文字典" id="word_name104_1" style="color:#000000;font-size:14px;text-decoration:none;line-height:16px;font-family: arial;" >英文字典中文字典</a></div><table width=100% style='align:center;text-align:left;font-size:12px;background-color:#ffffff;color:#333333;'>
<tr><td style="text-align:center;border:0"><input type=hidden name="word104_hi" value="1">输入中英文单字</td></tr><tr><td style="text-align:center;border:0"><input type="text" name="word104_input" value="" size=10 style="background-color:#ffffff;color:#000;text-decoration:none;font-family: arial;rial;border:1px solid #999;padding:1px!important;"></td></tr><tr style='line-height: 26px;'><td style="text-align:center;border:0"><input type=submit style="background-color:#ccc;color:#000;border:0 none;cursor:pointer;" value="查询字典"></td></tr></table></div>
</form>

英文字典中文字典相关资料:

Home - Mesoblast Ltd
Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care
Mesoblast Limited (MESO)
Find the latest Mesoblast Limited (MESO) stock quote, history, news and other vital information to help you with your stock trading and investing
Mesoblast - Wikipedia
Mesoblast Limited is an Australian regenerative medicine company It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain The company is led by Silviu Itescu, who founded the company in 2004 [1]
Mesoblast finally pushes GvHD cell therapy over finish line
Mesoblast has secured FDA approval for the first-ever mesenchymal stem cell (MSC) therapy, Ryoncil for acute GvHD in children undergoing HSCT
After two rejections, FDA approves Mesoblasts GVHD cell therapy
After two rejections from the FDA, Mesoblast has finally gained approval for its first drug, Ryoncil, a cell therapy for graft versus host disease
Top-Notch Biotech Mesoblast Skyrockets On Immune Condition Approval
Mesoblast snagged Food and Drug Administration approval for the first-ever treatment for children with a form of graft vs host disease The top-notch biotech stock rocketed Thursday
Overview - Mesoblast Ltd
Mesoblast is a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions
FDA approves Mesoblast’s Ryoncil for SR-aGvHD treatment
Mesoblast has gained US Food and Drug Administration (FDA) approval for its mesenchymal stromal cell (MSC) therapy, Ryoncil (remestemcel-L), to treat steroid-refractory acute graft versus host disease (SR-aGvHD) in paediatric patients aged a minimum of two months and up to adolescents and teenagers
Long-awaited FDA approval for Mesoblast marks a first in the U. S.
At long last, Mesoblast has gained its first FDA approval — nearly a decade after Japan’s regulatory agency approved the same product, an allogeneic bone marrow-derived mesenchymal stromal cell therapy for GvHD
Mesoblast’s RYONCIL® is the First U. S. FDA-Approved Mesenchymal Stromal . . .
NEW YORK, Dec 18, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced the Food and Drug

中文字典-英文字典 2005-2009